, Tracking Stock Market Picks
Enter Symbol:
Kindred Healthcare, Inc. (KND) [hlAlert]

Mkt Outperform
up 18.58 %

Kindred Healthcare, Inc. (KND) rated Mkt Outperform with price target $24 by Avondale

Posted on: Thursday,  Dec 17, 2009  11:25 AM ET by Avondale

Avondale rated Mkt Outperform Kindred Healthcare, Inc. (NYSE: KND) on 12/17/2009, when the stock price was $17.43.
Since then, Kindred Healthcare, Inc. has gained 18.59% as of 01/20/2016's recent price of $20.67.
If you would have followed this Avondale's recommendation on KND, you would have gained 18.58% of your investment in 2225 days.

Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates hospitals, nursing centers and a contract rehabilitation services business across the United States. As of December 31, 2008, the Company's hospital division operated 82 long-term acute care (LTAC) hospitals (6,482 licensed beds) in 24 states. Kindred Healthcare's health services division operated 228 nursing centers (28,525 licensed beds) in 27 states. The Company also operated a contract rehabilitation services business that provides rehabilitative services primarily in long-term care settings. Kindred Healthcare is organized into three operating divisions: the hospital division, the health services division and the rehabilitation division. In September 2008, the Company discontinued its operations in LTAC hospital in Massachusetts and California.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2009 11:25 AM Buy
17.43 24.00
as of 12/31/2009
1 Week down  -1.45 %
1 Month up  9.06 %
3 Months   
1 YTD up  9.06 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy